Induction of regulated upon activation, normal T cells expressed and secreted (RANTES) and transforming growth factor-β1 in airway epithelial cells by Mycoplasma pneumoniae

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 3 I, 2003, Pages 344-351

  Dakhama, Azzeddine ^a   Kraft, Monica ^a   Martin, Richard J ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ERYTHROMYCIN; RANTES; TRANSFORMING GROWTH FACTOR BETA1;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASTHMA; BACTERIAL INFECTION; BACTERIUM ADHERENCE; DRUG EFFECT; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PROTEIN INDUCTION; RESPIRATORY EPITHELIUM;

ASTHMA; BRONCHI; CELL ADHESION; CELL LINE; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; EPITHELIAL CELLS; ERYTHROMYCIN; GLUCOCORTICOIDS; HUMANS; KINETICS; MYCOPLASMA; MYCOPLASMA PNEUMONIAE; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA PNEUMONIAE;

EID: 0042831340     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0291OC     Document Type: Article

References (36)

1. Denny, F. W., W. A. Clyde, and W. P. Glezen. 1971. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J. Infect. Dis. 123:74-92.
2. Principi, N., and S. Esposito. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in pediatric patients. Curr. Opin. Infect. Dis. 15:295-300.
3. Kraft, M., G. H. Cassell, J. E. Henson, H. Watson, J. Williamson, B. P. Marmion, C. A. Gaydos, and R. J. Martin. 1998. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158:998-1001.
4. Martin, R. J., M. Kraft, H. W. Chu, E. A. Berns, and G. H. Cassell. 2001. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107:595-601.
5. Lieberman, D., D. Lieberman, M. Ben-Yaakov, O. Shmarkov, Y. Gelfer, R. Varshavsky, B. Ohana, Z. Lazarovich, and I. Boldur. 2002. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. Diagn. Microbiol. Infect. Dis. 44:1-6.
6. Seggev, J. S., G. V. Sedmak, and V. P. Kurup. 1996. Isotype-specific antibody responses to acute Mycoplasma pneumoniae infection. Ann. Allergy Asthma Immunol. 77:67-73.
7. Koh, Y. Y., Y. Park, H. J. Lee, and C. K. Kim. 2001. Levels of interleukin-2, interferon-gamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 107:E39
8. Hoek, K. L., G. H. Cassell, L. B. Duffy, and T. P. Atkinson. 2002. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J. Allergy Clin. Immunol. 109:470-476.
9. Mok, J. Y., P. R. Waugh, and H. Simpson. 1979. Mycoplasma pneumonia infection: a follow-up study of 50 children with respiratory illness. Arch. Dis. Child. 54:506-511.
10. Kraft, M., G. H. Cassell, J. Pak, and R. J. Martin. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121:1782-1788.
11. Feizi, T., and R. W. Loveless. 1996. Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences. Am. J. Respir. Crit. Care Med. 154:S133-S136.
12. Rawlinson, C. A., H. W. Chu, J. A. Campbell, R. Harbeck, and R. J. Martin. 2002. Optical density of Mycoplasma pneumoniae is predictable of colony forming units in culture. Am. J. Respir. Crit. Care Med. 165:A184. (Abstr.)
13. Dakhama, A., R. G. Hegele, G. Laflamme, E. Israel-Assayag, and Y. Cormier. 1999. Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 159:1316-1322.
14. Ling, E., and D. S. Robinson. 2002. Transforming growth factor-beta1: its anti-inflammatory and pro-fibrotic effects. Clin. Exp. Allergy 32:175-178.
15. Lyons, R. M., L. E. Gentry, A. F. Purchio, and H. L. Moses. 1990. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110:1361-1367.
16. Taipale, J., J. Lohi, J. Saarinen, P. T. Kovanen, and J. Keski-Oja. 1995. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270:4689-4696.
17. Schultz-Cherry, S., and J. E. Murphy-Ullrich. 1993. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:923-932.
18. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, and A. S. Fauci. 1986. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167-4171.
19. Edwards, D. R., G. Murphy, J. J. Reynolds, S. E. Whitham, A. J. Docherty, P. Angel, and J. K. Heath. 1987. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1899-1904.
20. Redington, A. E., J. Madden, A. J. Frew, R. Djukanovic, W. R. Roche, S. T. Holgate, and P. H. Howarth. 1997. Transforming growth factor-beta 1 in asthma: measurement in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 156:642-647.
21. Minshall, E. M., D. Y. Leung, R. J. Martin, Y. L. Song, L. Cameron, P. Ernst, and Q. Hamid. 1997. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17:326-333.
22. Vignola, A. M., P. Chanez, G. Chiappara, A. Merendino, E. Pace, A. Rizzo, A. M. la Rocca, V. Bellia, G. Bonsignore, and J. Bousquet. 1997. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 156:591-599.
23. Holgate, S. T. 2000. Epithelial damage and response. Clin. Exp. Allergy 30:37-41.
24. Sime, P. J., Z. Xing, F. L. Graham, K. G. Csaky, and J. Gauldie. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100:768-776.
25. Evans, M. J., L. S. Van Winkle, M. V. Fanucchi, and C. G. Plopper. 1999. The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. Am. J. Respir. Cell Mol. Biol. 21:655-657.
26. Miyazono, K., P. ten Dijke, and C. H. Heldin. 2000. TGF-beta signaling by Smad proteins. Adv. Immunol. 75:115-157.
27. Redington, A. E. 2000. Airway fibrosis in asthma: mechanisms, consequences, and potential for therapeutic intervention. Monaldi Arch. Chest Dis. 55:317-323.
28. Teran, L. M. 2000. CCL chemokines and asthma. Immunol. Today 21:235-242.
29. Alam, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153:1398-1404.
30. Holgate, S. T., K. S. Bodey, A. Janezic, A. J. Frew, A. P. Kaplan, and L. M. Teran. 1997. Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am. J. Respir. Crit. Care Med. 156:1377-1383.
31. Fryer, A. A., M. A. Spiteri, A. Bianco, M. Hepple, P. W. Jones, R. C. Strange, R. Makki, G. Tavernier, F. I. Smilie, A. Custovic, A. A. Woodcock, W. E. Ollier, and A. H. Hajeer. 2000. The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun. 1:509-514.
32. Hizawa, N., E. Yamaguchi, S. Konno, Y. Tanino, E. Jinushi, and M. Nishimura. 2002. A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am. J. Respir. Crit. Care Med. 166:686-690.
33. Kazachkov, M. Y., P. C. Hu, J. L. Carson, P. C. Murphy, F. W. Henderson, and T. L. Noah. 2002. Release of cytokines by human nasal epithelial cells and peripheral blood mononuclear cells infected with Mycoplasma pneumoniae. Exp. Biol. Med. 227:330-335.
34. Hahn, D. L., D. Bukstein, A. Luskin, and H. Zeitz. 1998. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann. Allergy Asthma Immunol. 80:45-49.
35. Garey, K. W., I. Rubinstein, M. H. Gotfried, I. J. Khan, S. Varma, and L. H. Danziger. 2000. Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest 118:1826-1827.
36. Wales, D., and M. Woodhead. 1999. The anti-inflammatory effects of macrolides. Thorax 54:S58-S62.